Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 05 2022 - 5:40PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
May 5, 2022
Commission File Number: 001-36686
Forward Pharma A/S
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Item 1. Notice to Convene Annual General Meeting
On May 5, 2022, Forward Pharma A/S (the “Company”)
mailed to its shareholders a notice to convene the 2022 annual general meeting of shareholders on May 20, 2022 and accompanying documentation.
The notice and accompanying documentation have been posted on the Company’s website, http://forward-pharma.com, and are being furnished
as exhibits to this Report on Form 6-K.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
FORWARD PHARMA A/S |
|
|
|
|
|
|
Date: May 5, 2022 |
By: |
/s/ Claus Bo Svendsen |
|
|
Name: Claus Bo Svendsen |
|
|
Title: Chief Executive Officer |
EXHIBIT INDEX
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Oct 2023 to Oct 2024